Search results
Results From The WOW.Com Content Network
alpha-1 ( α1) adrenergic receptors are G protein-coupled receptors (GPCRs) associated with the G q heterotrimeric G protein. α 1 -adrenergic receptors are subdivided into three highly homologous subtypes, i.e., α 1A -, α 1B -, and α 1D -adrenergic receptor subtypes. There is no α 1C receptor.
Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia ...
The data suggest that the Type 1 probands die mainly from cancer, type 2 from CHD, whereas Type 3 and especially Type 4 probands show a much lower death rate. Two additional types of personalities were measured Type 5 and Type 6. Type 5 is a rational anti-emotional type, which shows characteristics common to Type 1 and Type 2.
Adrenergic blocking agent. Adrenergic blocking agents are a class of drugs that exhibit its pharmacological action through inhibiting the action of the sympathetic nervous system [1] in the body. The sympathetic nervous system (SNS) is an autonomic nervous system that we cannot control by will. It triggers a series of responses after the body ...
Alpha adrenoreceptor ligands mimic the action of epinephrine and norepinephrine signaling in the heart, smooth muscle and central nervous system, with norepinephrine being the highest affinity. The activation of α 1 stimulates the membrane bound enzyme phospholipase C , and activation of α 2 inhibits the enzyme adenylate cyclase .
3. Breathing problems. "It felt like my heart took off to sprint a marathon and left my body behind," says , who was just 26 when she had two heart attacks, one in 2011 and one in 2012. "My heart ...
Grade 1 hypertension. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial, also known as ALLHAT, was a randomized, double-blind, active-controlled study comparing at the same time, four different classes of antihypertensive drugs with the rate of coronary heart disease (CHD) events in ‘high-risk’ people with hypertension.
When bound by adenosine, A 1 receptors inhibit impulses generated in supraventricular tissue (SA node, AV node) and the Bundle of His/Purkinje system, leading to negative chronotropy (slowing of the heart rate). [9] Specifically, A 1 receptor activation leads to inactivation of the inwardly rectifying K + current and inhibition of the inward Ca ...